首頁 > 市場調查報告書 > 製藥

消化器

北美急性胰臟炎市場預測至 2030 年 - 區域分析 - 按產品、原因和最終用戶

市場調查報告書

商品編碼

1452546

北美急性胰臟炎市場預測至 2030 年 - 區域分析 - 按產品、原因和最終用戶

North America Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

出版日期: 2024年01月03日 | 出版商:

The Insight Partners | 英文 94 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美急性胰臟炎市值為32.0963億美元，預計到2030年將達到5,00071萬美元；預計2022年至2030年CAGR為5.7%。

急性胰臟炎引起的胰臟癌病例增加推動了北美急性胰臟炎市場

胰臟癌是西方國家癌症相關死亡的第四大原因。根據美國癌症協會《2022 年癌症事實與數據》，預計到 2030 年，胰臟癌的死亡率將成為美國所有癌症死亡率中第二高的癌症。如果不及早發現，胰臟癌更有可能進展。腫瘤是可以切除的。根據 2021 年國家醫學圖書館發表的一篇文章，只有約 15% 的胰臟腫瘤在診斷時可以切除，五年存活率限制在 8%。然而，缺乏早期症狀導致這些腫瘤的診斷不佳和可切除性較低。急性胰臟炎可能導致胰臟癌，因為它是胰臟癌的早期症狀，近 1% 的急性胰臟炎入院患者會被診斷為胰臟癌。這些患者在診斷出急性胰臟炎後需要幾個月的時間才能被診斷為胰臟癌，但有些患者因最初的誤診而遭受更長的診斷延誤，這可能會阻礙他們的康復。急性胰臟炎反覆發生會導致慢性胰臟炎，可能進一步增加胰臟癌的風險。

根據美國國家糖尿病、消化和腎臟疾病研究所的數據，急性胰臟炎每年導致約 275,000 人入院，而這一數字在美國一直在增加。在美國，約 35-40% 的急性胰臟炎病例是由膽結石引起的，而飲酒是造成 30% 病例的原因。 80% 的入院患者的胰臟炎通常是輕度的，大多數可以在住院幾天內出院。急性胰臟炎的死亡率約為 2%，復發率在 0.6% 至 5.6% 之間。酒精相關性胰臟炎的復發率最高。根據2022年發表在《刺胳針胃腸病學肝病學》上的一篇文章，全球急性胰臟炎的總發病率為每年每10萬人中34例。北美每年每 10 萬人中有 58.2 例（美國每年每 10 萬人有 58.2 例），而歐洲的瑞典和丹麥分別為每 10 萬人 24.7 例和 15.0 例。

急性胰臟炎會導致消化酵素釋放到胰臟間質而不是胰管腔中，由於腫瘤阻塞胰管，急性胰臟炎可能是胰臟癌的早期指標。急性胰臟炎是一種痛苦的疾病，因此患者應儘早醫，這可能有助於早期癌症診斷。因此，急性胰臟炎引起的胰臟癌病例的增加促進了北美急性胰臟炎市場的成長。

北美急性胰臟炎市場概況

北美急性胰臟炎市場分為美國、加拿大和墨西哥。 2022年，美國在該地區佔據最大市場佔有率，預計在預測期內將繼續保持主導地位。北美急性胰臟炎市場預計將成長，因為膽結石病例增加和過量飲酒導致急性胰臟炎負擔增加。此外，隨著醫療保健設施技術進步的增加，北美市場預計在預測期內將成長。

北美急性胰臟炎市場收入及 2030 年預測（百萬美元）

北美急性胰臟炎市場細分

北美急性胰臟炎市場按產品、原因、最終用戶和國家進行細分。

根據產品類型，北美急性胰臟炎市場分為藥物、診斷等。 2022年，診斷細分市場佔據最大市場佔有率。

根據病因，北美急性胰臟炎市場分為膽結石、酗酒、遺傳性疾病、感染等。 2022 年，膽結石細分市場佔據最大的市場佔有率。

根據最終用戶，北美急性胰臟炎市場分為醫院、診斷實驗室、門診手術中心等。 2022 年，醫院細分市場佔據最大市場佔有率。

根據國家/地區，北美急性胰臟炎市場分為美國、加拿大和墨西哥。 2022年，美國在北美急性胰臟炎市場佔有率中佔據主導地位。

Abbott Laboratories、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是北美急性胰臟炎市場的一些領先公司。

主要市場促進因素
- 急性胰臟炎導致胰臟癌病例增加
- 急性胰臟炎後糖尿病發生率上升
主要市場限制
- 胰臟炎和胰臟癌治療的副作用
主要市場機會
- 急性胰臟炎的研發活動和宣傳項目數量激增
未來的趨勢
- 特異性急性胰臟炎治療的進展
影響分析：

第 6 章：急性胰臟炎市場 - 北美市場分析

北美急性胰臟炎市場收入，2022 - 2030

第 7 章：北美急性胰臟炎市場 - 收入和 2030 年預測 - 按產品分類

概述
2022 年及 2030 年北美急性胰臟炎市場收入佔有率（按產品分類）
藥物
診斷
其他

第 8 章：北美急性胰臟炎市場 - 收入和 2030 年預測 - 按原因

概述
2022 年及 2030 年北美急性胰臟炎市場收入佔有率（按原因分類）
膽結石
酗酒
遺傳性疾病
感染
其他

第 9 章：北美急性胰臟炎市場 - 收入和 2030 年預測 - 按最終用戶

概述
北美急性胰臟炎市場收入佔有率（按最終用戶），2022 年和 2030 年 (%)
醫院
診斷實驗室
門診手術中心
其他

第 10 章：北美急性胰臟炎市場 - 國家分析

概述

第 11 章：北美急性胰臟炎市場-產業格局

概述
北美急性胰臟炎市場的成長策略
無機成長策略
- 概述
有機成長策略
- 概述

第 12 章：公司簡介

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

第 13 章：附錄

簡介目錄圖表

Product Code: BMIRE00029237

The North America acute pancreatitis market was valued at US$ 3,209.63 million in 2022 and is expected to reach US$ 5,000.71 million by 2030; it is estimated to grow at a CAGR of 5.7% from 2022 to 2030.

Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis Fuels the North America Acute Pancreatitis Market

Pancreatic cancer is the fourth leading cause of cancer-related mortality in Western countries. According to the American Cancer Society, Cancer Facts & Figures 2022, the mortality rate of pancreatic cancer is predicted to be the second highest among all cancer-led mortality rates in the US by 2030. It is more likely to progress if not detected early when the tumor is resectable. According to an article published in the National Library of Medicine in 2021, only ~15% of pancreatic tumors are resectable at diagnosis, limiting five-year survival to 8%. However, the lack of early symptoms results in poor diagnosis and low resectability of these tumors. Acute pancreatitis may cause pancreatic cancer as it is an early symptom of pancreatic cancer, nearly 1% of acute pancreatitis admissions result in pancreatic cancer diagnoses. It takes several months for these patients to be diagnosed with pancreatic cancer after acute pancreatitis is diagnosed, but some suffer longer diagnostic delays due to initial misdiagnosis, which may hinder their recovery. Recurrent occurrence of acute pancreatitis leads to chronic pancreatitis, which may further increase the risk of pancreatic cancer.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, acute pancreatitis leads to ~275,000 hospital admissions each year, and this number has been increasing in the US. ~35-40% of acute pancreatitis cases in the US are due to gallstones, while alcohol consumption is the cause of 30% of cases. Pancreatitis is usually mild in 80% of patients who are admitted, and most can be discharged within a few days of their hospitalization. Acute pancreatitis is associated with a mortality rate of ~2% and has a relapse rate between 0.6% and 5.6%. Alcohol-related pancreatitis has the highest rate of relapse. According to an article published in Lancet Gastroenterology Hepatology in 2022, the global pooled incidence of acute pancreatitis is 34 cases per 100,000 per year. North America has 58.2 cases per 100,000 people per year (the US has 58.2 cases per 100,000 people per year) while Europe has 24.7 and 15.0 cases per 100,000 people in Sweden and Denmark, respectively.

Acute pancreatitis, which causes the release of digestive enzymes into the pancreatic interstitial space instead of the pancreatic duct lumen, could be an early indicator of pancreatic cancer due to tumor obstruction of the pancreatic duct. Acute pancreatitis is a painful condition, so patients seek medical care sooner, which could lead to an early cancer diagnosis. Therefore, rising cases of pancreatic cancer due to acute pancreatitis boosts the growth of the North America acute pancreatitis market.

North America Acute Pancreatitis Market Overview

The North America acute pancreatitis market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. the North America acute pancreatitis market in North America is expected to grow due to the increasing burden of acute pancreatitis due to increase in cases of gallstones and excessive consumption of alcohol. Also, with an increase in technological advancement in healthcare facilities, the market in North America is expected to grow during the forecast period.

North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

North America Acute Pancreatitis Market Segmentation

The North America acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the North America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on causes, the North America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the North America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America acute pancreatitis market is segmented into the US, Canada, and Mexico. The US dominated the North America acute pancreatitis market share in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the North America acute pancreatitis market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 North America Acute Pancreatitis Market, by Country (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Acute Pancreatitis Market Landscape

4.1 Overview

5. North America Acute Pancreatitis Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - North America Market Analysis

6.1 North America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. North America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 North America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 North America Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 North America Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 North America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. North America Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the North America Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medtronic Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Boston Scientific Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Fresenius Kabi AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Acute Pancreatitis Market Segmentation
Table 2. North America Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. US: North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. US: North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. US: North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada: North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada: North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada: North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada: North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico: North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico: North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico: North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico: North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico: North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the North America Acute Pancreatitis Market
Table 20. Recent Organic Growth Strategies in the North America Acute Pancreatitis Market
Table 21. Glossary of Terms, North America Acute Pancreatitis Market

List Of Figures

Figure 1. North America Acute Pancreatitis Market Segmentation, By Country
Figure 2. North America Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Acute Pancreatitis Market, by Key Country - Revenue (2022) (US$ Million)
Figure 21. North America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. US: North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Canada: North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Mexico: North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the North America Acute Pancreatitis Market